
Expert rheumatologist and dermatologist discuss biosimilars and impact of biosimilars on the field of rheumatology and dermatology.

Expert rheumatologist and dermatologist discuss biosimilars and impact of biosimilars on the field of rheumatology and dermatology.

Experts in dermatology discuss presentation and treatment of atopic dermatitis (AD) in patients with skin of color SOC). Through a discussion of patient cases, they present rationale for where and why they would use recently approved AD treatments in pediatric population.

Susan Taylor, MD, FAAD, provides an overview of sun-caused skin damage.

James Q. Del Rosso, DO, and Neal Bhatia, MD, discuss the role of topical and oral JAK inhibitors in inflammatory disease management.

Linda Stein Gold, MD, and Matthew Zirwas, MD, provide a discussion on the role of JAK inhibitors in inflammatory diseases.

Expert dermatologists provide an overview of vitiligo while reviewing presentation, diagnosis, and the goals of therapy related to current and future therapies.

In this expert series, Adelaide Hebert, MD, chief of pediatric dermatology at the McGovern Medical School at UTHealth Houston, Texas, provides an overview of eczema while discussing environmental factors of the skin condition, the role of emollients and moisturizers, and how ceramide containing creams can help.